NYLI WMC Value Class A (MAPAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
28.24
+0.64 (2.32%)
Apr 22, 2025, 2:52 PM EDT
-0.28% (1Y)
| Fund Assets | 1.03B |
| Expense Ratio | 1.10% |
| Min. Investment | $15,000 |
| Turnover | n/a |
| Dividend (ttm) | 1.57 |
| Dividend Yield | 5.25% |
| Dividend Growth | 24.45% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 9, 2024 |
| Previous Close | 27.60 |
| YTD Return | -3.65% |
| 1-Year Return | 4.85% |
| 5-Year Return | 99.89% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 71 |
| Inception Date | Jan 21, 1971 |
About MAPAX
The NYLI WMC Value Class A (MAPAX) seeks to earn income as a secondary objective. MAPAX normally invests at least 65% of its total assets in equity-type securities.
Fund Family MainStay Fds A
Category Large Value
Performance Rating Above Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol MAPAX
Share Class Class A
Index Russell 1000 Value NR
Performance
MAPAX had a total return of 4.85% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.95%.
Top 10 Holdings
24.27% of assets| Name | Symbol | Weight |
|---|---|---|
| JPMorgan Chase & Co. | JPM | 3.98% |
| UnitedHealth Group Incorporated | UNH | 3.35% |
| Johnson & Johnson | JNJ | 3.10% |
| Cisco Systems, Inc. | CSCO | 2.47% |
| Pfizer Inc. | PFE | 1.97% |
| American International Group, Inc. | AIG | 1.97% |
| Elevance Health, Inc. | ELV | 1.93% |
| MetLife, Inc. | MET | 1.85% |
| Gilead Sciences, Inc. | GILD | 1.84% |
| Merck & Co., Inc. | MRK | 1.81% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 9, 2024 | $1.57019 | Dec 9, 2024 |
| Dec 6, 2023 | $1.26168 | Dec 6, 2023 |
| Dec 7, 2022 | $1.58752 | Dec 7, 2022 |
| Dec 2, 2021 | $25.77691 | Dec 2, 2021 |
| Dec 2, 2020 | $1.67369 | Dec 2, 2020 |
| Dec 2, 2019 | $3.50589 | Dec 2, 2019 |